SCHEMBL4304196

SCHEMBL4304196

Cc1cc(-c2ccc3c(c2)CCC(N2CCCC2)C3)ccc1C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL3 Q96JM7 5/20 0.41
L3MBTL1 Q9Y468 5/20 0.41
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
PDE4D Q08499 1/20 0.39
PDE7A Q13946 1/20 0.39
CDC7 O00311 1/20 0.39
CDK9 P50750 1/20 0.39
FAAH O00519 1/20 0.39
TP53BP1 Q12888 1/20 0.37
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
AXL P30530 1/20 0.36
ETV6 P41212 1/20 0.36
HTR1D P28221 2/20 0.36
HRH3 Q9Y5N1 1/20 0.35
GFER P55789 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4666095 0.88 HSP90AA1 (0.39) L3MBTL3L3MBTL1CDC7CDK9FAAH
SCHEMBL4135754 0.83 HRH3 (0.42) L3MBTL3PDE4DFAAHHRH3ALDH1A1
SCHEMBL4137087 0.83 HTR1D (0.41) L3MBTL3L3MBTL1FAAHHTR1DOPRL1
SCHEMBL4771706 0.81 AXL (0.37) L3MBTL3L3MBTL1CDC7CDK9FAAH
SCHEMBL4132414 0.81 HRH3 (0.45) L3MBTL3L3MBTL1FAAHTP53BP1HTR1D
SCHEMBL4140118 0.81 TDP2 (0.45) L3MBTL3L3MBTL1FAAHHTR1DHRH3
SCHEMBL4144270 0.81 TDP2 (0.45) L3MBTL3L3MBTL1FAAHHTR1DHRH3
SCHEMBL4140115 0.81 TDP2 (0.45) L3MBTL3L3MBTL1FAAHHTR1DHRH3
SCHEMBL4133407 0.80 HTR1A (0.43) FAAHHTR1DOPRL1KCNH2
SCHEMBL4136102 0.80 FAAH (0.44) L3MBTL3L3MBTL1FAAHTP53BP1ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090163482-A1 TETRALINES ANTAGONISTS OF THE H-3 RECEPTOR MCHARDY STANTON FURST 2009-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090163482-A1 TETRALINES ANTAGONISTS OF THE H-3 RECEPTOR HRH3, HRH4, HRH1 L3MBTL3 3062/4885L3MBTL1 3712/4885MKNK1 4068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.